Osteoarthritis as part of metabolic syndrome?

Česká verzia

Authors: Karel Pavelka
Authors place of work: Revmatologický ústav, Praha
Published in the journal: Vnitř Lék 2017; 63(10): 707-711
Category: Reviews

Summary

Osteoarthritis (OA) is the most frequent joint disease, whereas etiopathogenesis of OA is not entirely clarified. It is a heterogeneous disorder and genetic as well as biomechanical, endocrine and inflammatory effects may be involved in its origin. The author examines the problems concerning relationships between the metabolic syndrome and OA, and states that the prevalence of metabolic syndrome in patients with OA is higher than in those without OA (59 % vs 23 %). It remains problematic that one of the main components of metabolic syndrome is obesity which in itself is a risk factor for arthrosis development in the weight-bearing joints, not for OA in the hands. After adjustment for BMI the relationships between the metabolic syndrome and OA are less expressed. Over the last decade evidence has been gained about adipose tissue being the source of numerous cytokines and adipokines which may cause inflammation of low-activity synovial tissue, sometimes also called “meta-inflammation.” The most data was gathered on leptin, resistin, adiponectin and visfatin. Mostly there were serum levels of these adiponectins assessed and the results were sometimes inconsistent. Two studies have been published this year presenting a histological and immunohistochemical evaluation of the fat stored in 2 tissues right in the joints of patients with metabolic syndrome and OA, and the fat on an experimental OA model, concluding that the secretion activity of the potentially pro-inflammatory adipokines through adipocytes may differ in the synovial membrane, infrapatellar fat body and in abdominal fat. It is evident that the components of metabolic syndrome and OA can share a common pathological process which is an “adipose tissue associated inflammation.” The changed secretion profile of pro-inflammatory adipokines is present in obese individuals, an older population and postmenopausal women, the populations at high risk for both metabolic syndrome and OA. Significant mechanical loads may stimulate OA of the knee joints in obese patients, however not of the hands, and further differences between arthrosis of the knee joints and the hands. The adipose tissue induced inflammation is the common pathological mechanism for both metabolic syndrome and OA and it may account for some of the variations.

Key words:
adiponectins – metabolic syndrome – osteoarthritis

Zdroje

1. Qin J, Barbour KE, Murphy LB et al. Lifetime risk of symptomatic hand osteoarthritis. Arthritis Rheum 2017; 69(6): 1204–1212. Dostupné z DOI: <http://dx.doi.org/10.1002/art.40097>.

2. Xie F, Kovic B, Xuejing J et al. Economic and humanistic burden of OA: a systematic review of large sample studies. Pharmacoeconomics 2016; 34(11): 1087–1100.

3. Altman R, Asch E, Bloch D et al. Development of criteria for classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29(8): 1039–1049.

4. Appleton CT, Hawker GA, Hill CL et al. Weighing in the Framingham Osteoarthritis study: Measuring biomechanical and metabolic contributions to osteoarthritis. Arthritis Rheumatology 2017; 69(6): 1127–1130. Dostupné z DOI: <http://dx.doi.org/10.1002/art.40089>.

5. Bijlsma H, Berenbaum F, Lefebr FP. Osteoarthritis an update with relevance for clinical practice. Lancet 2011; 377(9783): 2115–2126. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140–6736(11)60243–2>.

6. Svačina Š. Obezitologie a teorie metabolického syndromu. Triton: Praha 2013. ISBN 978–80–7387–678–4.

7. Puenpatom RA, Victor TW. Increased prevalence of metabolic syndrome in individuals with osteoarthritis.an analysis of NHANES III, data. Postgrad Med 2009; 121(6): 9–20. Dostupné z DOI: <http://dx.doi.org/10.3810/pgm.2009.11.2073>.

8. Christensen R, Bartels EM, Astrup A et al. Effect of weight reduction in obese patients with knee OA: a systematic review and meta-analysis. Ann Rheum Dis 2007; 66(4): 433–439.

9. Buchholz AL, Niesen MC, Gausden EB et al. Metabolic activity of osteoarthritis knees correlates with BMI. Knee. 2010; 17(2): 161–166. Dostupné z DOI: <http://dx.doi.org/10.1016/j.knee.2009.07.012>.

10. Visser AW, De Mutsert R, Cessie S et al. The relative contribution of mechanical stress and systemic processes in different types of osteoarthritis NEO study. Ann Rheum Dis 2015; 74(10): 1842–1847. Dostupné z DOI: <http://dx.doi.org/10.1136/annrheumdis-2013–205012>.

11. Monira Hussain S, Wang Y, Cicuttini FM et al. Incidence of total knee and hip replacement for osteoarthritis in relation to the metabolic syndrome and its components: a prospective cohort study. Semin Arthritis Rheum 2014; 43(4): 429–436. Dostupné z DOI: <http://dx.doi.org/.1016/j.semarthrit.2013.07.013>.

12. Niu J, Clancy M, Aliabadi P et al. Metabolic syndrome, its components and knee osteoarthritis. Arthritis Rheum 2017; 69(6): 1194–1203. Dostupné z DOI: <http://dx.doi.org/10.1002/art.40087>.

13. Jin X, Begurie JR, Zhang W et al. Circulating C reactive protein in osteoarthritis: a systematic review and metaanalysis. Ann Rheum Dis 2015; 74(4): 703–710. Dostupné z DOI: <http://dx.doi.org/10.1136/annrheumdis-2013–204494>.

14. Kluzek S, Newton JL, Arden NK. Is osteoarthritis a metabolic disorder? Br Med Bull 2015; 115(1): 111–121. Dostupné z DOI: <http://dx.doi.org/10.1093/bmb/ldv028>.

15. Engtsrom G, Gerhardson de Verdier M, Rollof J et al. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population based cohort study. Osteoarthritis Cartilage 2009; 17(2): 168–173. Dostupné z DOI: <http://dx.doi.org/10.1016/j.joca.2008.07.003>.

16. Bos SD, Suchiman HE, Kloppwenburg M et al. Allelic variation at the C-reactive protein gene associates to both hand osteoarthritis severity and serum high sensitive C reactive protein levels in the GARP study. Ann Rheum Dis 2008; 67(6): 877–879.

17. Yusuf E, Ioan-Fascinay A, Bijsterbosch J et al. Association between leptin, adiponectin and resistin and long term progression of hand OA. Ann Rheum Dis 2011; 70(7): 1282–1284. Dostupné z DOI: <http://dx.doi.org/10.1136/ard.2010.146282>.

18. Fowler-Brown A, Kim DH, Shi I et al. The mediating effect of leptin on the relationship between body weight and knee osteoarthritis in older adults. Arthritis Rheumatol 2015; 67(1): 169–175. Dostupné z DOI: <http://dx.doi.org/10.1002/art.38913>.

19. Filková M, Lišková M, Hulejová H et al. Increased serum adiponectin levels in female patients with erosive compared with non-erosive osteoarthritis. Ann Rheum Dis 2009; 68(2): 295–296. Dostupné z DOI: <http://dx.doi.org/10.1136/ard.2008.095737>.

20. Aktas E, Sener E, Gocun PU. Mechanically induced experimental knee osteoarthritis benefits from anti-inflammatory and immunomodulatory properties of simvastatin via inhibition of matrix metalloproetinase-3. J Orhop Traumatol 2011; 12(3): 145–151. Dostupné z DOI: <http://dx.doi.org/10.1007/s10195–011–0154-y>.

21. Visser AV, Ioan-Fascinay A, de Mutsert R et al. Adiposity and hand osteoarthritis: the study Netherlands epidemiology and obesity study. Arthrit Res Ther 2014; 16(1): R19. Dostupné z DOI: <http://dx.doi.org/10.1186/ar4447>.

22. Harasymowicz NS, Clement ND, Azfer A et al. Regional differences between perisynovial and infrapatellar adipose tissue depots and their response to class III obesity in patients with osteoarthritis. Arthritis Rheumatol 2017; 69(7): 1396–1406. Dostupné z DOI: <http://dx.doi.org/10.1002/art.40102>.

23. Barboza E, Hudson J, Wan-Pin CH et al. Profibrotic infrapatellar fat pad remodelling without M1 macrophage polarization proceeds knee osteoarthritis in mice with diet-induced obesity. Arthritis Rheumatology 2017; 69(6): 1221–1232. Dostupné z DOI: <http://dx.doi.org/10.1002/art.40056>.

24. Courties A, Sellam J, Berenbaum F. Metabolic syndrome-associated osteoarthritis. Curr Opin Rheumatol 2017; 29(2): 214–222. Dostupné z DOI: <http://doi: 10.1097/BOR.0000000000000373>.